Brexpiprazole
Brand names: REXULTI RXULTI
Therapeutic Indications
Brexpiprazole is indicated for:
Schizophrenia
Irrespective of gender only Adults (18 - 65 years old)
Brexpiprazole is indicated for the treatment of schizophrenia in adult patients.
For this indication, the medical literature mentions below treatments (click for details):
Treatment 1: Oral - 1-4 mg once daily
Contraindications
Active ingredient Brexpiprazole is contraindicated in the following cases: